Coefficient Bio
Biotech · AI
Anthropic Acquires Coefficient Bio in $400M Stock Deal
Raised
$400M
Anthropic has acquired stealth biotech startup Coefficient Bio for over $400 million in stock, integrating its AI-driven drug discovery team into its life sciences group. The deal highlights AI's expanding role in biological research and pharma innovation.
Anthropic acquired Coefficient Bio, a stealth biotech startup founded eight months ago and backed by Dimension, in a deal valued at just over $400 million paid in stock. The startup specialized in AI models for biological research, including drug discovery, research planning, and regulatory strategy development. Coefficient Bio's small team will join Anthropic's Healthcare Life Sciences team, led by Eric Kauderer-Abrams, to advance AI tools for biotech workflows. Dimension, which held half ownership, achieved a 38,513% IRR on its investment in the young company.
Read More About This Story
Get the app
Stay Ahead With Velocity
Deep company profiles, investor context, and every original source behind this story — plus the next one, the moment it breaks.
